United Therapeutics Corporation (UTHR) Total assets 2016–2025
United Therapeutics Corporation (UTHR) total assets at each fiscal year-end, per SEC filings.
$7.9BFY2025 · since FY2016: $2.3B → $7.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.9B | +7.0% |
| FY2024 | $7.4B | +2.7% |
| FY2023 | $7.2B | +18.6% |
| FY2022 | $6.0B | +16.9% |
| FY2021 | $5.2B | +12.0% |
| FY2020 | $4.6B | +17.9% |
| FY2019 | $3.9B | +15.1% |
| FY2018 | $3.4B | +18.1% |
| FY2017 | $2.9B | +23.8% |
| FY2016 | $2.3B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More UTHR financial trends
UTHR RevenueUTHR Net incomeUTHR Net marginUTHR Gross profitUTHR Gross marginUTHR Operating incomeUTHR Operating marginUTHR Operating cash flowUTHR Free cash flowUTHR Capital expendituresUTHR Return on equityUTHR Stock buybacksUTHR Dividends paidUTHR Total liabilitiesUTHR Shareholders’ equityUTHR overview →